miR-383 is a tumor suppressor that inhibits cell proliferation, metastasis, and EMT in BC via targeting ETS1 [68], which can also suppress cell cycle progression in gastric carcinoma cells through regulating Cyclin E2 expression [69]. Here, CCNE2 is linked to neoplasm.